FDBusiness.com

Meiogenix, Lesaffre partner on yeast

 Breaking News
  • Arla Foods Achieves Record Organic Revenue Growth in 2017 Strong performances by Arla Foods’ global brands, its international markets, and the ingredients business ensured a year of high growth for international dairy co-operative Arla Foods in 2017, as it delivered a 27.4% increase in pre-paid milk price to its farmer owners, and a net profit of 2.8% of revenue within its target range. This was [...]...
  • Solid 2017 Performance From Kerry Group Kerry Group, the global taste, nutrition and consumer foods business, has reported a 4.5% increase in revenue to €6.4 billion for the year ended 31 December 2017, reflecting strong volume growth offset by adverse currency movements. Group trading profit increased by 4.2% to €781.3 million. Kerry Group’s Taste & Nutrition business reported revenue increased by 5.7% [...]...
  • DSM to Exclusively Market BIOMILK 300 Residual Lactose Analyzer DSM, a global science-based company active in health, nutrition and materials, will exclusively market BIOMILK 300, a compact residual lactose-analyzing device produced by BIOLAN, as from February 2018. For dairy producers, the BIOMILK 300 is a fast, cost-effective, and accurate analyzer for quantifying residual lactose levels in lactose-free and lactose-reduced dairy products. Consumers are increasingly aware [...]...
  • Food & Drink Innovation at Forefront of UK’s Largest Packaging Show Innovation will take centre stage when the UK’s largest packaging event, Packaging Innovations, Empack and Label&Print 2018, returns to the NEC later this month. In its most innovative show to date, visitors will be able to discover the latest cutting-edge products and new industry developments, alongside more sustainable packaging than ever before. Highlights include: Colpac will be [...]...
  • EU Agri-food Exports are Holding Strong The value of EU agri-food exports reached €137.9 billion in 2017, corresponding to a sustained increase by 5.1% in value terms compared to 2016. Published by the European Commission, the latest monthly trade report details the export values for different sectors and origin. Major gains in annual values have been achieved in agri-food exports to the USA [...]...

Meiogenix, Lesaffre partner on yeast

June 07
11:13 2016

Bakers-YeastMeiogenix and Lesaffre have partnered up to develop improved industrial yeast strains using Meiogenix’s recombination technologies. The PhoeniX technology developed by Meiogenix controls the process of natural meiotic recombination and generates efficiently non–GM recombined yeast cells particularly for industrial strains where meiosis is impeded.

Meiogenix is a French biotech company that develops technologies to increase the genetic diversity of organisms by modulating meiosis and targeting recombination. Under the collaboration agreement Meiogenix will apply its non-GM technology to discover novel yeast strains with improved industrial properties that will be then industrialized by Lesaffre, a global key player in yeasts and fermentation.

“We are delighted of this collaboration with Lesaffre, a worldwide key player in the industrial yeast field. In the last few years we have carried out several R&D projects in yeast and we are glad to put into play the expertise and technologies we have developed,” said Giacomo Bastianelli, Co-founder & CEO of Meiogenix. “We believe that PhoeniX, a proprietary non-GM technology, can have a major impact in the yeast industry, especially for food applications where mainstream genetic engineering technologies are not yet an accepted option.”

The global market value for industrial yeast is projected to grow at a CAGR (compounded annual growth rate) of 8.8% and expected to reach $3.6B by 2018. The recent advances in genetic engineering techniques (e.g. CRISPR/CAS9, synthetic biology) can have an unprecedented impact in the development of novel yeast strains but severe concerns about genetically modified organisms used in the food and beverage industry are still a major hurdle for any development and commercialization. Therefore, research efforts will aim at developing new screening methods and technologies for the isolation of natural recombinants with the desired properties.

“Innovation has always been at the heart of Lesaffre’s development,” said Didier Colavizza, R&D Biotech Center Director at Lesaffre. “Research and Development is one of Lesaffre’s key drivers for success. Being the brainchild of Dr. Alain Nicolas, a scientist at the Institut Curie, Meiogenix’s innovative technology represents for us an opportunity to generate diversity in yeast. As an alternative to mutagenesis, this technique can improve yeasts and be applied in many fields from baking yeast to biofuels.”

Meiogenix, launched in 2011, is a biotech company developing breeding technologies to unlock the unexplored genetic diversity of organisms.

Lesaffre is a French yeast manufacturer, and the world’s largest producer. The company was founded by Louis Lesaffre, the co-founder of Bonduelle, in the mid-19th century.

About Author

admin

admin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • February 25, 2018fish international
  • February 27, 2018Warsaw Gastro Show
  • February 27, 2018Int'l Food Fair
  • February 28, 2018GAST
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements